SAVA - Cassava Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
1,319
2,969
7,615
9,176
9,100
Selling General and Administrative
3,318
3,693
4,334
5,781
5,102
Total Operating Expenses
4,637
6,662
11,949
14,957
14,202
Operating Income or Loss
-4,637
-6,662
-11,949
-14,957
-14,202
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
0
0
Income Before Tax
-4,362
-6,557
-11,911
-14,850
-14,145
Income Tax Expense
-
-
-
-
0
Income from Continuing Operations
-4,362
-6,557
-11,911
-14,850
-14,145
Net Income
-4,362
-6,557
-11,911
-14,850
-14,145
Net Income available to common shareholders
-4,362
-6,557
-11,911
-14,850
-14,145
Reported EPS
Basic
-
-0.61
-1.82
-2.31
-2.17
Diluted
-
-0.61
-1.82
-2.31
-2.17
Weighted average shares outstanding
Basic
-
10,682
6,537
6,520
6,537
Diluted
-
10,682
6,537
6,520
6,537
EBITDA
-
-6,593
-11,881
-14,899
-14,202